Clinical Now with Featured Trials from the American Heart Association Scientific Sessions 2009!

In this section we'll be highlighting the major late-breaking trials in endocrinology coming out of the AHA's Scientific Sessions. This will make it easier for our users to reference the details of these trials while they're in Orlando, or off-site from anywhere in the world where they have a connection.

So far we have Featured Trials that coincide with AHA late-breaking abstracts being presented on:

  • Abstract LCBT.01; POPULAR: Evaluation and Comparison of Several Point-of-Care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-Treated Patients Undergoing Elective PCI (NCT00352014)
  • Abstract LCBT.01; PLATO: A Comparison of AZD6140 and Clopidogrel in Patients With Acute Coronary Syndrome (NCT00391872)
  • Abstract LCBT.02; ARBITER-6 HALTS: Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis (NCT00397657)
  • Abstract LCBT.02; TREAT: Trial to Reduce Cardiovascular Events With Aranesp® Therapy (NCT00093015)
  • Abstract LCBT.03; CASCADE: Trial of Clopidogrel After Surgery for Coronary Artery Disease (NCT00228423)
  • Abstract LCBT.03; POPE: Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion (NCT00247052)
  • Abstract LCBT.04; FAIR-HF: Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (NCT00520780)
  • Abstract LCBT.04; HeartMate II: Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy (NCT00121485)

Be sure to check your Featured Trials listing as we add more to the page and keep up with the AHA's Scientific Sessions 2009!

Download Clinical from the App Store, or see our Featured Trials demo video below (flash required).